Cartography Biosciences is a startup, 1 tracked investor.
Cartography Biosciences is a startup. Brouky records 1 investor associated with the company.
Cartography Biosciences develops precise cancer immunotherapies by using single-cell genomics and proprietary computational platforms to identify specific and safe tumor targets across a broad range of cancers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.